---
$id: https://graph.org.ai/products/commodity/51142503
$type: Product
source: UNSPSC
code: "51142503"
title: "Levodopa"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Levodopa

**UNSPSC Code**: 51142503
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine agonist with the molecular formula C9H11NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 46627O600J, chemically known as 3,4-dihydroxyphenyl-l-alanine but generally known as levodopa, which bears US NIH Compound Identifier 836. European Medicines Agency schedules Levodopa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08468MIG. The term LEVODOPA is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules levodopa in its Anatomical Therapeutic Chemical (ATC) Classification. LEVODOPA is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule levodopa under HS 29225000 and SITC 51467. As of Q4 2014, LEVODOPA remains the US FDA Preferred Term for this commodity. Levodopa bears US NLM identifiers UMLS ID C0699991 and NCI Concept Code C611. SMILES: OC1CC(CC(N)C(=O)O)CCC1O.

